Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

• Status: Completed
• Trial end date: 2015-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to evaluate the drug-drug interaction between Erdosteine and Bepotastine besilate in healthy adult volunteers.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Daewoong Pharmaceutical Co. LTD.
• Treatments: Bepotastine besilate; Erdosteine

Criteria

Inclusion Criteria:

• Healthy male subjects aged 20 - 45 years

• A body mass index in the range 18.5 - 25 kg/m2

• Willingness to participate during the entire study period

• Written informed consent after being fully informed about the study procedures

Exclusion Criteria:

• Any past medical history of hepatic, renal, gastrointestinal, respiratory, endocrine, psychiatric, neurologic, haemato-oncologic or cardiovascular disease

• History of clinically significant drug hypersensitivity

• Use of medication within 7 days before the first dose

• Heavy drinker/smoker

• Whole blood donation during 60 days before the study

• Judged not eligible for study participation by investigator